Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1578 of 6351
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383. The main questions if aims to answer are: * Does CP-383 slow or stop the growth of cancer in patients with advanced cancer…
Phase 1/2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pill Q702 aims to outsmart blood cancers in early trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of Q702 in treating patients with hematologic malignancies. Q702 is in a class of medications called immunomodulatory agents. It works by helping the immune system kill cancer cells and by helping the bone marrow to…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Real-World study tracks Ribociclib's impact on early breast cancer
Disease control Recruiting nowThis is a non-interventional, prospective, single-arm, observational study describing the real-world effectiveness, safety, and PRO and HCRU data of ribociclib combined with adjuvant ET under conditions of routine clinical practice in HR+/HER2- EBC in premenopausal, perimenopausa…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Your phone could soon spot a hidden heart condition
Diagnosis By invitation onlyThe purpose of this 4-in-1 observational study is to test the performance of artificial intelligences (AIs) in distinguishing irregularly irregular heart rhythm called atrial fibrillation (AF) from normal heart rhythm using physiological signals collected by smartphones' built-in…
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New therapy could beat CBT for anxiety – but is it too early to tell?
Symptom relief Recruiting nowBackground Anxiety disorders are the most prevalent psychiatric disorders around the world. Effective treatment consists of pharmacotherapy or psychological treatment based on cognitive-behavioral therapy (CBT) and these treatment options are recommended in clinical guidelines,…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Fiber and probiotics: a new hope for bloating and irregularity?
Symptom relief CompletedThis is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of BelliWelli Daily Fiber + Probiotics supplement on gut health over 12 weeks. One hundred participants with self-reported gut health issues will be randomized to receive either the activ…
Sponsor: Belli Welli Inc. • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New study tests clotting drug to stop dangerous bleeding after birth
Disease control Recruiting nowThis study will look at how safe is the medicine eptacog alfa when used in women in India for stopping heavy bleeding after giving birth. If participants have heavy bleeding after giving birth then they will get the medicine eptacog alfa. This study will be conducted to get more …
Phase 4 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Tribal schools test culturally smart program to keep kids healthy
Prevention Recruiting nowThe goal of this study is to learn if a culturally relevant health promotion curricula prevents obesity among 4th graders in rural tribal schools. The main questions it aims to answer are: 1) Does the health promotion curricula intervention increase diet and physical activity beh…
Sponsor: Northern Arizona University • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
New shot could tame tough eczema in phase 2 trial
Disease control OngoingThe goal of this interventional study is to learn if TRIV-509 works to treat moderate to severe atopic dermatitis in adults. It will also evaluate the safety of TRIV-509. Participants will receive 4 doses of the study intervention that they are randomized to (TRIV-509 or placebo…
Phase 2 • Sponsor: Triveni Bio • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Could a Marijuana-Derived drug help treat sleep apnea?
Disease control Recruiting nowThis is an open-label trial that tests the effectiveness of Dronabinol in treating obstructive sleep apnea (OSA). All participants will take oral Dronabinol for two weeks. Sleep studies will be conducted before and after treatment to measure OSA severity.
Phase 1/2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Brain zaps may tame sensory overload in kids with autism
Symptom relief By invitation onlyThe goal of this clinical trial is to find out if brain stimulation can help improve sensory integration in children ages 6 to 12 with autism spectrum disorder (ASD). The main questions it aims to answer are: Does brain stimulation using continuous theta-burst stimulation (cTBS)…
Sponsor: Neurolab Plus • Aim: Symptom relief
Last updated Jun 26, 2026 19:17 UTC
-
Hormone boost may sharpen prostate cancer scans
Diagnosis Recruiting nowThis phase II trial studies how well a short course of androgen deprivation therapy (ADT) with relugolix works in increasing expression of prostate-specific membrane antigen (PSMA) and improving diagnostic imaging with PSMA positron emission tomography (PET)/computed tomography (…
Phase 2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New cancer drug TJ101 enters first human trials for advanced tumors
Disease control Recruiting nowThe goal of this clinical trial is to evaluate whether TJ101, an investigational antibody-drug conjugate (ADC), can safely and effectively treat patients with advanced solid tumors. The main objectives of this study are : * To Determine the maximum tolerated dose (MTD) and reco…
Phase 1 • Sponsor: Phrontline Biopharma • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a cancer drug shrink birthmarks? bleomycin injections put to the test
Disease control CompletedThis study evaluated lesion volume reduction after intralesional bleomycin sclerotherapy in patients with low-flow vascular malformations of the head and neck, and identified predictors of treatment response. Twenty patients were enrolled across three Iraqi teaching hospitals and…
Phase 4 • Sponsor: University Of Anbar • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New injection shows promise for shedding pounds in early trial
Disease control Recruiting nowThis is a multicenter, double-blind, randomized, placebo-controlled phase Ⅱ study to evaluate the efficacy, safety, pharmacokinetics, and immunogenicity of YN-011 in subjects with overweight (27 kg/m2 ≤ BMI \< 30 kg/m2, with at least one comorbidity) or obesity (BMI ≥ 30 kg/m2, w…
Phase 2 • Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New shingles drug brivudine aims to beat standard treatment in pain battle
Disease control Recruiting nowThis multicenter RCT aims to compare the efficacy and safety of Brivudine versus Famciclovir in treating acute herpes zoster. Primary objective: Evaluate pain reduction via Numeric Pain Rating Scale (NPRS) at Day 30. Secondary objectives: Compare NPRS at Day 3/Day 7/Day 14/Day 90…
Phase 4 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New lupus drug YK012 enters human trials – hope for patients?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of YK012 in participants with Moderate to Severe Systemic Lupus Erythematosus (SLE).
Phase 1/2 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Promising combo therapy for aggressive prostate cancer tested before surgery
Disease control Stopped earlyA randomized, open-label Phase I/II study of neoadjuvant treatment with \[177Lu\]Lu-PSMA-617 radioligandtherapy (LuPSMA) with or without Ipilimumab in participants with very high-risk prostate cancer who are candidates for Radical Prostatectomy.
Phase 1/2 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug aimed at kidney disease shows promise in early trial
Disease control Recruiting nowTo evaluate the safety and tolerability of three dose regimens of budoprutug in subjects with PMN
Phase 2 • Sponsor: Climb Bio, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
First gene therapy injection targets rare brain disorder
Disease control By invitation onlyThis is gene therapy study of an AAV9 vector carrying the SLCA1 gene for SLC6A1 neurodevelopmental disorder.
Phase 1/2 • Sponsor: Emily de los Reyes • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC